Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Aquestive Therapeutics
AQST
$492M
| $417K | ﹤0.01% |
462,737
-438,063
| -49% | -$411K |
|
|
CYPH
3052
Cypherpunk Technologies Inc
CYPH
$71.7M
| $417K | ﹤0.01% |
92,570
+53,440
| +137% | +$357K |
|
3053
Dare Bioscience
DARE
$19.9M
| $416K | ﹤0.01% |
41,724
-12,443
| -23% | -$139K |
|
3054
Telephone and Data Systems
TDS
$4.1B
| $415K | ﹤0.01% |
+39,584
| New | +$490K |
|
3055
ProShares Short Bitcoin Strategy ETF
BITI
$120M
| $414K | ﹤0.01% |
+2,080
| New | +$407K |
|
|
OCFT
3056
DELISTED
OneConnect Financial Technology
OCFT
| $414K | ﹤0.01% |
78,060
-2,310
| -3% | -$15.9K |
|
3057
Dimensional US Core Equity 2 ETF
DFAC
$49.1B
| $413K | ﹤0.01% |
17,000
-40,800
| -71% | -$992K |
|
3058
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.6B
| $413K | ﹤0.01% |
+10,100
| New | +$413K |
|
3059
Silicom
SILC
$239M
| $413K | ﹤0.01% |
9,803
+4,003
| +69% | +$165K |
|
|
EEX
3060
DELISTED
Emerald Holding
EEX
| $411K | ﹤0.01% |
116,057
-19,580
| -14% | -$70.2K |
|
3061
Dorchester Minerals
DMLP
$1.25B
| $410K | ﹤0.01% |
13,700
+1,000
| +8% | +$28.8K |
|
|
HI
3062
DELISTED
Hillenbrand
HI
| $410K | ﹤0.01% |
9,600
-34,600
| -78% | -$1.53M |
|
3063
VirnetX Holding Corp
VHC
$67M
| $408K | ﹤0.01% |
15,697
-15,273
| -49% | -$378K |
|
3064
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.02B
| $406K | ﹤0.01% |
9,900
-14,700
| -60% | -$648K |
|
3065
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.34B
| $406K | ﹤0.01% |
3,300
-1,100
| -25% | -$140K |
|
3066
AYTU BioPharma
AYTU
$25M
| $405K | ﹤0.01% |
107,039
+19,663
| +23% | +$74K |
|
3067
Vanguard FTSE Europe ETF
VGK
$31.1B
| $405K | ﹤0.01% |
+7,300
| New | +$385K |
|
3068
Bank7 Corp
BSVN
$479M
| $404K | ﹤0.01% |
15,800
+4,420
| +39% | +$112K |
|
3069
Cue Biopharma
CUE
$113M
| $404K | ﹤0.01% |
4,723
-9,482
| -67% | -$867K |
|
3070
JPMorgan Diversified Return International Equity ETF
JPIN
$373M
| $404K | ﹤0.01% |
+8,200
| New | +$386K |
|
3071
KALA BIO
KALA
$14.2M
| $404K | ﹤0.01% |
212
+37
| +21% | +$14.6K |
|
3072
Pulmatrix
PULM
$6.06M
| $404K | ﹤0.01% |
104,120
-8,100
| -7% | -$29.3K |
|
3073
Pliant Therapeutics
PLRX
$65M
| $402K | ﹤0.01% |
20,800
-73,500
| -78% | -$1.54M |
|
3074
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.64B
| $402K | ﹤0.01% |
+16,200
| New | +$387K |
|
|
LND
3075
BrasilAgro
LND
$358M
| $401K | ﹤0.01% |
70,500
-39,700
| -36% | -$220K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.